Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1995; 26:864-869
© 1995 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chiale, P.
Right arrow Articles by Hoebeke, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiale, P.
Right arrow Articles by Hoebeke, J

High prevalence of antibodies against beta 1- and beta 2-adrenoceptors in patients with primary electrical cardiac abnormalities

PA Chiale, MB Rosenbaum, MV Elizari, A Hjalmarson, Y Magnusson, G Wallukat, and J Hoebeke

Division of Cardiology, Ramos Mejia Hospital, Buenos Aires, Argentina.

OBJECTIVES. This study sought to determine the prevalence of autoantibodies directed against the beta-adrenoceptors in patients with primary electrical cardiac abnormalities, including atrial arrhythmias, ventricular arrhythmias and conduction disturbances, in the absence of any other cardiac abnormality. BACKGROUND. Using synthetic peptides corresponding to the predicted sequences for the second extracellular loop of the human beta 1- and beta 2-adrenoceptors as antigenic targets, autoantibodies directed against the beta-adrenoceptors were recently shown to occur in patients with idiopathic dilated cardiomyopathy and Chagas' heart disease. METHODS. Eighty-six patients (57 with primary electrical abnormalities, 29 with idiopathic dilated cardiomyopathy) and 101 healthy and cardiopathic control subjects were studied. Antibodies against the beta 1- and beta 2-peptides were detected with an enzyme immunoassay performed in blinded manner. In nine selected (seropositive) cases, the immunoglobulin G (IgG) fraction was tested for functional effects on the rate of beating of cultured neonatal rat cardiomyocytes. RESULTS. Antibodies recognizing the beta 1- and beta 2-peptides were found in 11 (52.3%) of 21 patients with ventricular arrhythmias (p < 0.01), 5 (35.7%) of 14 patients with conduction disturbances (p < 0.05), 3 (13.6%) of 22 patients with atrial arrhythmias (p > 0.05) and 11 (37.9%) of 29 patients with dilated cardiomyopathy (p < 0.05) compared with 15 (14.8%) of 101 control subjects. A rapid increase in the rate of beating of the cultured cardiomyocytes was induced by IgG from a selected group of patients, suggesting an agonist-like interaction with a functional epitope. This response was mediated by stimulation of both the beta 1- and beta 2-adrenoceptors in the patients with primary ventricular arrhythmias but only the beta 1-adrenoceptors in the patients with idiopathic dilated cardiomyopathy. CONCLUSIONS. Primary ventricular arrhythmias and conduction disturbances, like idiopathic cardiomyopathy, show a high prevalence of antibodies interacting with functional epitopes of the beta-adrenoceptors, suggesting a common or similar abnormal immunoregulatory process.


This article has been cited by other articles:


Home page
EuropaceHome page
E. H. Medei, J. H.M. Nascimento, R. C. Pedrosa, L. Barcellos, M. O. Masuda, S. Sicouri, M. V. Elizari, and A. C. Campos de Carvalho
Antibodies with beta-adrenergic activity from chronic chagasic patients modulate the QT interval and M cell action potential duration
Europace, July 1, 2008; 10(7): 868 - 876.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. d. L. Higuchi, L. A. Benvenuti, M. Martins Reis, and M. Metzger
Pathophysiology of the heart in Chagas' disease: current status and new developments
Cardiovasc Res, October 15, 2003; 60(1): 96 - 107.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Iwata, T. Yoshikawa, A. Baba, T. Anzai, H. Mitamura, and S. Ogawa
Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy
J. Am. Coll. Cardiol., February 1, 2001; 37(2): 418 - 424.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Mijares, D. Lebesgue, G. Wallukat, and J. Hoebeke
From Agonist To Antagonist: Fab Fragments of an Agonist-Like Monoclonal Anti-beta 2-Adrenoceptor Antibody Behave as Antagonists
Mol. Pharmacol., August 1, 2000; 58(2): 373 - 379.
[Abstract] [Full Text]


Home page
FASEB J.Home page
M. O. Masuda, M. Levin, S. F. De oliveira, P. C. Dos Santos Costa, P. L. Bergami, N. A. Dos Santos Almeida, R. C. Pedrosa, I. Ferrari, J. Hoebeke, and A. C. Campos de Carvalho
Functionally active cardiac antibodies in chronic Chagas' disease are specifically blocked by Trypanosoma cruzi antigens
FASEB J, November 1, 1998; 12(14): 1551 - 1558.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Kaplan, I. Ferrari, P. L. Bergami, E. Mahler, G. Levitus, P. Chiale, J. Hoebeke, M. H. V. Van Regenmortel, and M. J. Levin
Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus
PNAS, September 16, 1997; 94(19): 10301 - 10306.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement